Cite
Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.
MLA
Lefebvre, Patrick, et al. “Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.” Clinical Therapeutics, vol. 39, no. 7, July 2017, p. 1380. EBSCOhost, https://doi.org/10.1016/j.clinthera.2017.05.356.
APA
Lefebvre, P., Muser, E., Joshi, K., DerSarkissian, M., Bhak, R. H., Duh, M. S., Shiner, B., & Young-Xu, Y. (2017). Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse. Clinical Therapeutics, 39(7), 1380. https://doi.org/10.1016/j.clinthera.2017.05.356
Chicago
Lefebvre, Patrick, Erik Muser, Kruti Joshi, Maral DerSarkissian, Rachel H Bhak, Mei Sheng Duh, Brian Shiner, and Yinong Young-Xu. 2017. “Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.” Clinical Therapeutics 39 (7): 1380. doi:10.1016/j.clinthera.2017.05.356.